CONFORMATIONAL ASPECTS CRITICAL TO THE IMMUNOSPECIFICITY OF THE TYPE-III GROUP-B STREPTOCOCCAL POLYSACCHARIDE

被引：105
|
作者：
JENNINGS, HJ
LUGOWSKI, C
KASPER, DL
机构：
[1] PETER BENT BRIGHAM HOSP,DEPT MED,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,CHANNING LAB,BOSTON,MA 02115
来源：
BIOCHEMISTRY | 1981年 / 20卷 / 16期
关键词：
D O I：
10.1021/bi00519a001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：4511 / 4518
页数：8
相关论文
共 50 条
  • [41] GROUP-B STREPTOCOCCI INVADE ENDOTHELIAL-CELLS - TYPE-III CAPSULAR POLYSACCHARIDE ATTENUATES INVASION
    GIBSON, RL
    LEE, MK
    SODERLAND, C
    CHI, EY
    RUBENS, CE
    INFECTION AND IMMUNITY, 1993, 61 (02) : 478 - 485
  • [42] IMMUNOGENICITY IN ANIMALS OF A POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE AGAINST TYPE-III GROUP-B STREPTOCOCCUS
    WESSELS, MR
    PAOLETTI, LC
    KASPER, DL
    DIFABIO, JL
    MICHON, F
    HOLME, K
    JENNINGS, HJ
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05): : 1428 - 1433
  • [43] IMMUNOGENICITY OF POLYSACCHARIDES FROM TYPE-III, GROUP-B STREPTOCOCCUS
    BAKER, CJ
    EDWARDS, MS
    KASPER, DL
    JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (04): : 1107 - 1110
  • [44] SEROEPIDEMIOLOGY OF GROUP-B STREPTOCOCCUS TYPE-III COLONIZATION AT DELIVERY
    GRAY, BM
    PRITCHARD, DG
    DILLON, HC
    JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (06): : 1139 - 1142
  • [45] IGG SUBCLASS LEVELS IN NEONATES WITH GROUP-B TYPE-I, TYPE-II, AND TYPE-III STREPTOCOCCAL SEPSIS
    MADANI, G
    KIM, K
    ANTHONY, B
    HEINER, DC
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (01) : 290 - 290
  • [46] DISTRIBUTION AND FUNCTIONAL-ACTIVITY OF HUMAN-IGG SUBCLASS-SPECIFIC ANTIBODIES TO NATIVE TYPE-III GROUP-B STREPTOCOCCAL (III-GBS) POLYSACCHARIDE
    GIVNER, LB
    EDWARDS, MS
    BAKER, CJ
    PEDIATRIC RESEARCH, 1985, 19 (04) : A294 - A294
  • [47] CORRELATION BETWEEN THE PRODUCTION OF EXTRACELLULAR SUBSTANCES BY TYPE-III GROUP-B STREPTOCOCCAL STRAINS AND VIRULENCE IN A MOUSE MODEL
    DURHAM, DL
    MATTINGLY, SJ
    DORAN, TI
    MILLIGAN, TW
    STRAUS, DC
    INFECTION AND IMMUNITY, 1981, 34 (02) : 448 - 454
  • [48] PROTECTIVE LEVEL OF HUMAN-IGG ANTIBODY TO THE TYPE SPECIFIC POLYSACCHARIDE OF GROUP-B STREPTOCOCCUS (GBS) TYPE-III
    GOTOFF, SP
    ODELL, C
    PAPIERNIAK, CK
    KLEGERMAN, ME
    BOYER, KM
    PEDIATRIC RESEARCH, 1985, 19 (04) : A294 - A294
  • [49] IMMUNOLOGICAL ASPECTS OF GROUP-B STREPTOCOCCAL INFECTIONS
    KRETSCHMER, RR
    GOTOFF, SP
    INFECTION, 1978, 6 (04) : 146 - 148
  • [50] PREVENTION OF C3 DEPOSITION BY CAPSULAR POLYSACCHARIDE IS A VIRULENCE MECHANISM OF TYPE-III GROUP-B STREPTOCOCCI
    MARQUES, MB
    KASPER, DL
    PANGBURN, MK
    WESSELS, MR
    INFECTION AND IMMUNITY, 1992, 60 (10) : 3986 - 3993
12345